The Trader
01-06
I think Novo Nordisk would continue to outperform. The market for weight loss drug seems endless, with plenty of growth left in the US, without even accounting for international growth. though it's hard to predict the actual percentage change, I think a 20% increase is a reasonable guess.
Review Your 2023 Investment Decisions
How was your 2023? We would like to invite you to review your investment decisions over the past year. All Tigers who write posts or comments containing more than 50 characters will receive 10 Tiger Coins. Additionally, you will have the opportunity to win exclusive prizes!
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment